SEE FULL COMPANY PROFILES WITH A FREE TRIAL
EMIS is the definitive emerging markets news, research, company, and financial data resource. EMIS - ISI Emerging MarketsLEARN MORE
Search for another company:
ALL
India
Company data displayed is for sample purposes only and may not reflect the most current information available on Emerging Markets Information Service (EMIS).

Ahlcon Parenterals India Ltd.

Main Activities: Chemical Manufacturing - Health and Personal Care Stores

facebook Please check the full coverage of information what EMIS can offer you. SEE SAMPLE

Company Information

Full name
Ahlcon Parenterals India Ltd.

Legal Address
Unit No. 201-205, Second Floor of ND Mall-1,, Plot No. 2-4, Wazirpur District Centre, Netaji Subhash Place; Delhi; Delhi; 110034
Status: Listed
Legal Form: Public Limited Company
Operational Status: Operational
ISIN CODE : INE027C01011
Financial Auditors: Arun K Gupta & Associates (2011)
Incorporation Date: January 20, 1992
Total Employees: 8,302

Tel: 011-42344234/ 42344218/

Company Description

The company in the pharmaceuticals business is manufacturer of intravenous fluids.
It was incorporated on 20 January, 1992 as a Public Limited company under the name and style Gujarat Inject (Rajasthan) Limited. Subsequently the name of t

Company Analysis

According to the Individual - Audited financial statement for the Year of 2012, total net operating revenues increased with 26.17%, from INR 62.79 tens of millions to INR 79.22 tens of millions. Operating result increased from INR 11.3 tens of millions to INR 13.43 tens of millions which means 18.85% change. The results of the period increased 23.36% reaching INR 5.07 tens of millions at the end of the period against INR 4.11 tens of millions last year. Return on equity (Net income/Total equity) went from 10.79% to 12.01%, the Return On Asset (Net income / Total Asset) went from 5.91% to 7.65% and the Net Profit Margin (Net Income/Net Sales) went from 6.55% to 6.40% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 59.34% compared to 83.91% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 2.44 to 1.83 when compared to the previous year.

Key Executives

Anand Apte Chairman
Manfred Mahrle Additional Director
Arun Mudgal Managing Director

Companies with Similar Main Activities

ISI Emerging Markets

FULL COMPANY PROFILE

Please check the full coverage of information what EMIS can offer you.
SEE SAMPLE
SELECT CURRENCY
Balance Sheet

Shareholders Equity

7

7

* All the accounts are in INR.
Income Statement

Total Operating Revenue

50

25

Operational Profit (Loss)

6

4

Net Profit (Loss)

4

2

* All the accounts are in INR.
Ratios
Profitability Ratios

Return on Equity (ROE)

56.53%

31.39%

Annualised Return on Equity (ROE)

113.06%

125.56%

Return on Sales (ROS)

102.32%

102.17%